454 Life Sciences and Baylor College of Medicine Complete Sequencing of DNA Project
The Genome of James Watson is the First to be Sequenced for Less than $1 Million
454 Life Sciences Corporation, in collaboration with scientists at the human genome Sequencing Center, Baylor College of medicine, announced the completion of a project to sequence the genome of James D. Watson, Ph.D., co-discoverer of the double-helix structure of DNA. The mapping of Dr. Watson's genome was completed using the Genome Sequencer FLX(TM) system and marks the first individual genome to be sequenced for less than $1 million, according to the company.
"When we began the Human Genome Project, we anticipated it would take 15 years to sequence the 3 billion base pairs and identify all the genes," said Richard Gibbs, Ph.D. , director, Human Genome Sequencing Center, Baylor College of Medicine. "We completed it in 13 years in 2003 - coinciding with the 50th anniversary of the publication of the work of Watson and Dr. Francis Crick that described the double helix. Today, we give James Watson a DVD containing his personal genome - a project completed in only two months. It demonstrates how far sequencing technology has come in a short time."
Christopher McLeod, president and CEO of 454 Life Sciences, added: "The sequencing of Dr. Watson's genome validates the approach taken by 454 Life Sciences in developing a technology to make the sequencing of individual human genomes quick and affordable. As we take another step on the path toward the X-Prize and reducing the cost of human genome sequencing to $10,000, we hope to enable a new era of medicine that is tailored to a patient's unique genetic profile."
Most read news
Topics
Organizations
Other news from the department research and development

Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.